Brief: AstraZeneca Says ZEGFROVY 200 Mg Administered Orally Once Daily Now Available In US
Yesterday 13:40
Oct 22 (Reuters) - AstraZeneca PLCAZN.L : * ZEGFROVY® (SUNVOZERTINIB) NOW AVAILABLE IN THE US FOR PATIENTS WITH PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATIONS * ASTRAZENECA - ZEGFROVY 200 MG ADMINISTERED ORALLY ONCE DAILY NOW AVAILABLE IN US Source text:ID:nBw8t55JCa Further company coverage:AZN.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsBrief: AstraZeneca Says ZEGFROVY 200 Mg Administered Orally Once Daily Now Available In US
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Brief: Abu Dhabi Biobank Partners With Astrazeneca To Advance Predictive Healthcare - AD Media Office
UK Stocks-Factors to watch on October 22 (updated)
Brief: AstraZeneca Says Ultomiris Approved In Us In IgAN